Clorox (CLX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the ...

Let’s dig into the relative performance of Clorox (NYSE:CLX) and its peers as we unravel the now-completed Q3 household products earnings ... Is now the time to buy Clorox?

Clorox (CLX ... complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>>. For the fiscal year ending June 2025, this consumer products maker is expected to earn $6.85 per share ...

Is now the time to buy Clorox? Access our full analysis of the earnings results here, it’s free. Formed after the 1928 combination between toothpaste maker Colgate and soap maker Palmolive-Peet, ...

Clorox (CLX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most ...

We retain BUY on MHL. We will incorporate the Core Diagnostics acquisition in our estimates once the transaction closes (within 60 days). We retain BUY on MHL, with unchanged TP of Rs2,400 (based ...

But it’s been a different story for healthcare stocks. This selloff extended losses healthcare stocks have seen since the end of August. While the first eight months of the year were strong ...

including distributors of healthcare products, providers of basic healthcare services and owners and operators of healthcare facilities and organizations. The second group of companies is ...